SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-091386
Filing Date
2024-04-10
Accepted
2024-04-10 07:30:37
Documents
17
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d818033d10ka.htm   iXBRL 10-K/A 344688
2 EX-31.3 d818033dex313.htm EX-31.3 3710
3 EX-31.4 d818033dex314.htm EX-31.4 3728
  Complete submission text file 0001193125-24-091386.txt   621528

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcrx-20231231.xsd EX-101.SCH 4765
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tcrx-20231231_cal.xml EX-101.CAL 647
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tcrx-20231231_def.xml EX-101.DEF 18391
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrx-20231231_lab.xml EX-101.LAB 25031
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrx-20231231_pre.xml EX-101.PRE 19642
20 EXTRACTED XBRL INSTANCE DOCUMENT d818033d10ka_htm.xml XML 10089
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40603 | Film No.: 24834256
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)